Replies to post #3683 on Galectin Therapeutics Inc. (GALT)

[buckysherm]

The former CEO Shlevin announced the 2b/3 trial months ago, and I got the impression that it was done as a lark and the company didn’t expect the trial to do well. Of course I knew that ain’t true, but that’s the tenor / timbre (?) he conveyed at the time.